These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 16553540)
1. Antidepressant use in children and adolescents in Germany. Fegert JM; Kölch M; Zito JM; Glaeske G; Janhsen K J Child Adolesc Psychopharmacol; 2006; 16(1-2):197-206. PubMed ID: 16553540 [TBL] [Abstract][Full Text] [Related]
2. Outpatient treatment in German adolescents with depression: an analysis of nationwide health insurance data. Hoffmann F; Glaeske G; Petermann F; Bachmann CJ Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):972-9. PubMed ID: 22639197 [TBL] [Abstract][Full Text] [Related]
3. Patterns and prevalence of antidepressant drug use in the German state of Baden-Wuerttemberg: a prescription-based analysis. Ufer M; Meyer SA; Junge O; Selke G; Volz HP; Hedderich J; Gleiter CH Pharmacoepidemiol Drug Saf; 2007 Oct; 16(10):1153-60. PubMed ID: 17443868 [TBL] [Abstract][Full Text] [Related]
4. Antidepressant drug use and off-label prescribing in children and adolescents in Germany: results from a large population-based cohort study. Dörks M; Langner I; Dittmann U; Timmer A; Garbe E Eur Child Adolesc Psychiatry; 2013 Aug; 22(8):511-8. PubMed ID: 23455627 [TBL] [Abstract][Full Text] [Related]
5. A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database. Murray ML; de Vries CS; Wong IC Arch Dis Child; 2004 Dec; 89(12):1098-102. PubMed ID: 15557040 [TBL] [Abstract][Full Text] [Related]
6. Incidence and prevalence of primary care antidepressant prescribing in children and young people in England, 1998-2017: A population-based cohort study. Jack RH; Hollis C; Coupland C; Morriss R; Knaggs RD; Butler D; Cipriani A; Cortese S; Hippisley-Cox J PLoS Med; 2020 Jul; 17(7):e1003215. PubMed ID: 32697803 [TBL] [Abstract][Full Text] [Related]
7. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Bachmann CJ; Aagaard L; Burcu M; Glaeske G; Kalverdijk LJ; Petersen I; Schuiling-Veninga CC; Wijlaars L; Zito JM; Hoffmann F Eur Neuropsychopharmacol; 2016 Mar; 26(3):411-9. PubMed ID: 26970020 [TBL] [Abstract][Full Text] [Related]
8. St John's wort and depression: slight efficacy at best, many drug interactions. Prescrire Int; 2004 Oct; 13(73):187-92. PubMed ID: 15499702 [TBL] [Abstract][Full Text] [Related]
9. Trends in prescriptions for antidepressant pharmacotherapy among US children and adolescents diagnosed with depression, 1990 through 2001: an assessment of accordance with treatment recommendations from the American Academy of Child and Adolescent Psychiatry. Skaer TL; Sclar DA; Robison LM Clin Ther; 2009 Jun; 31 Pt 1():1478-87. PubMed ID: 19698905 [TBL] [Abstract][Full Text] [Related]
10. [Antidepressants consumption in the global population in France]. Olié JP; Elomari F; Spadone C; Lépine JP Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542 [TBL] [Abstract][Full Text] [Related]
11. [Antidepressant and antipsychotic drug prescribing in Lombardy]. Percudani M; Barbui C; Fortino I; Tansella M; Petrovich L Epidemiol Psichiatr Soc; 2006; 15(1):59-70. PubMed ID: 16584104 [TBL] [Abstract][Full Text] [Related]
12. [Meta-analysis of effectiveness and tolerability of treatment of mild to moderate depression with St. John's Wort]. Röder C; Schaefer M; Leucht S Fortschr Neurol Psychiatr; 2004 Jun; 72(6):330-43. PubMed ID: 15211398 [TBL] [Abstract][Full Text] [Related]
13. Treatment of depression--newer pharmacotherapies. Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454 [TBL] [Abstract][Full Text] [Related]
14. About the cover: St. John's wort. J Soc Integr Oncol; 2006; 4(1):52-5. PubMed ID: 16737673 [TBL] [Abstract][Full Text] [Related]
15. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum). Markowitz JS; DeVane CL Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870 [TBL] [Abstract][Full Text] [Related]
16. Rising prevalence of antidepressants among US youths. Zito JM; Safer DJ; DosReis S; Gardner JF; Soeken K; Boles M; Lynch F Pediatrics; 2002 May; 109(5):721-7. PubMed ID: 11986427 [TBL] [Abstract][Full Text] [Related]
17. Effects of oral administration of extracts of Hypericum perforatum (St John's wort) on brain serotonin transporter, serotonin uptake and behaviour in mice. Hirano K; Kato Y; Uchida S; Sugimoto Y; Yamada J; Umegaki K; Yamada S J Pharm Pharmacol; 2004 Dec; 56(12):1589-95. PubMed ID: 15563766 [TBL] [Abstract][Full Text] [Related]
18. [High dose St. John's wort extract as a phytogenic antidepressant]. Kasper S; Schulz V Wien Med Wochenschr; 1999; 149(8-10):191-6. PubMed ID: 10483679 [TBL] [Abstract][Full Text] [Related]
19. Behavioral profile of Hypericum perforatum (St. John's Wort) extract. A comparison with standard antidepressants in animal models of depression. Bukhari IA; Dar A Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1082-9. PubMed ID: 23661522 [TBL] [Abstract][Full Text] [Related]
20. Trends in the use of antidepressants in a national sample of commercially insured pediatric patients, 1998 to 2002. Delate T; Gelenberg AJ; Simmons VA; Motheral BR Psychiatr Serv; 2004 Apr; 55(4):387-91. PubMed ID: 15067149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]